Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Operating Leases (2022 - 2025)

Mangoceuticals' Operating Leases history spans 4 years, with the latest figure at $307822.0 for Q4 2025.

  • On a quarterly basis, Operating Leases rose 373.85% to $307822.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $307822.0, a 373.85% increase, with the full-year FY2025 number at $307822.0, up 373.85% from a year prior.
  • Operating Leases hit $307822.0 in Q4 2025 for Mangoceuticals, up from $12167.0 in the prior quarter.
  • Over the last five years, Operating Leases for MGRX hit a ceiling of $307822.0 in Q4 2025 and a floor of $12167.0 in Q3 2024.
  • Historically, Operating Leases has averaged $94883.3 across 4 years, with a median of $97391.0 in 2023.
  • Biggest five-year swings in Operating Leases: plummeted 91.52% in 2024 and later skyrocketed 373.85% in 2025.
  • Tracing MGRX's Operating Leases over 4 years: stood at $128680.0 in 2022, then crashed by 49.52% to $64961.0 in 2023, then grew by 0.0% to $64962.0 in 2024, then skyrocketed by 373.85% to $307822.0 in 2025.
  • Business Quant data shows Operating Leases for MGRX at $307822.0 in Q4 2025, $12167.0 in Q3 2025, and $30117.0 in Q2 2025.